Microbot Other Monday, November 16, 2026 +0.10 Neutral

Microbot Files 10-Q as Commercial Efficiency Improves

Microbot Medical filed its third-quarter report showing a reduction in revenue due to seasonality and inventory valuation, while lowering manufacturing costs per unit and increasing procedures by 44%.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed